請勿錯過2012年令人矚目的活動

2012年8月6日∼8日
Westin San Francisco on Market Street
San Francisco, CA 94103

2012年主要的話題

Drug & Diagnostic Development 2012 是能將對疾病生物學特性的理解應用到臨床現場，聚焦於因應癌等疾病的新治療藥和引導開發診斷藥之抗體醫藥品開發領域的技術創新、生染色體組相關的實現技術、以及臨床生物標記策略等的活動。

Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies
-抗體藥物複合體、雙重特異性抗體和強化抗體-

• 下一代抗體藥物複合體
• 強化抗體和雙重特異性抗體

Next-Gen Sequencing Applications & Translational Technologies
-下一代排序的應用和翻譯的技術-

• 下一代排序之臨床及研究領域的應用
• 轉譯生物學和翻譯技術

The Future of Rx/Dx Summit
-與Rx/Dx的將來有關之高峰會議-

• Rx/Dx（治療藥和陪伴員診斷藥）的開發、商品化、合作的模式
• 未來的臨床診斷藥

Clinical Biomarkers & New Frontiers in Cancer
-癌的臨床生物標記與新的研究領域-

• 具臨床上意義的生物標記
• 癌的新研究領域：臨床研究的新框架

2011 Event Wrap-Up

On top of the perfect weather, attendees enjoyed hearing from the many keynote speakers and taking part in strategic discussion forums, benefiting from the opportunity to toss ideas around with their peers. Everyone from attendees to speakers, sponsors and exhibitors have told us what great contacts they've made at the event. Keep in touch and let us know what you thought by tweeting @drugdisc on twitter.com.

IBC's Drug Discovery & Diagnostic Development 2011 brought together five conference themes in one venue that highlighted emerging strategies and technologies so that you can continue to improve your drug development efforts from target discovery. Focused conference themes included:

• Empowered Antibody Therapies

• Next-Generation Sequencing & Genomic Medicine

• Next-Generation Molecular Diagnostics

• New Frontiers in Cancer

• Targeted Therapeutics